Protagonist Therapeutics Inc
PTGX
Market Cap$2.66B
Close$
$1.33
97% downside
Current Fair Value
97% downsideOvervalued by 97% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.66 Billion |
|---|---|
| Enterprise Value | $2.60 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $4.47 |
| Beta | 2.64 |
| Outstanding Shares | 62,328,468 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 9.73 |
|---|---|
| PEG | -370.87 |
| Price to Sales | 8.85 |
| Price to Book Ratio | 4.43 |
| Enterprise Value to Revenue | 8.03 |
| Enterprise Value to EBIT | 17.43 |
| Enterprise Value to Net Income | 15 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.05 |
Revenue Sources
No data
Insider Trades
ESG Score
No data